Consumer Health in Japan
In 2024, overall consumer health in Japan is set to see minimal retail current value growth. In terms of OTC categories, the number of influenza cases in 2024 has reached a higher level than in 2023, and infectious diseases such as group A streptococcal pharyngitis have also been prevalent, which is set to result in rising value sales for products such as systemic analgesics, combination products - cough, cold and allergy (hay fever) remedies, and cough remedies. Diarrhoeal remedies and motion s...
Euromonitor International's Consumer Health in Japan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.
Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
- Consumer Health in Japan
- Euromonitor International
- September 2024
- List Of Contents And Tables
- CONSUMER HEALTH IN JAPAN
- EXECUTIVE SUMMARY
- Consumer health in 2024: The big picture
- 2024 key trends
- Competitive landscape
- Retailing developments
- What next for consumer health?
- MARKET INDICATORS
- Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2019-2024
- Table 2 Life Expectancy at Birth 2019-2024
- MARKET DATA
- Table 3 Sales of Consumer Health by Category: Value 2019-2024
- Table 4 Sales of Consumer Health by Category: % Value Growth 2019-2024
- Table 5 NBO Company Shares of Consumer Health: % Value 2020-2024
- Table 6 LBN Brand Shares of Consumer Health: % Value 2021-2024
- Table 7 Penetration of Private Label in Consumer Health by Category: % Value 2019-2024
- Table 8 Distribution of Consumer Health by Format: % Value 2019-2024
- Table 9 Distribution of Consumer Health by Format and Category: % Value 2024
- Table 10 Forecast Sales of Consumer Health by Category: Value 2024-2029
- Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2024-2029
- APPENDIX
- OTC registration and classification
- Vitamins and dietary supplements registration and classification
- Self-medication/self-care and preventive medicine
- Switches
- DISCLAIMER
- DEFINITIONS
- SOURCES
- Summary 1 Research Sources
- ANALGESICS IN JAPAN
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Systemic analgesics sees a continued value growth trend due to persistent infections
- New products emerge in adult acetaminophen, in which OTC medication choices were limited
- Growth trend in topical analgesics/anaesthetic continues, supported by domestic and inbound demand
- PROSPECTS AND OPPORTUNITIES
- Diverse factors set to drive growth in analgesics
- Stocking of topical analgesics/anaesthetic to ensure disaster preparedness
- Encouraging a move to OTC medications as a fiscal measure
- CATEGORY DATA
- Table 12 Sales of Analgesics by Category: Value 2019-2024
- Table 13 Sales of Analgesics by Category: % Value Growth 2019-2024
- Table 14 NBO Company Shares of Analgesics: % Value 2020-2024
- Table 15 LBN Brand Shares of Analgesics: % Value 2021-2024
- Table 16 Forecast Sales of Analgesics by Category: Value 2024-2029
- Table 17 Forecast Sales of Analgesics by Category: % Value Growth 2024-2029
- COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN JAPAN
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Sales maintain slow growth, due to high infection rate but low pollen count
- Price adjustments for OTC medicines
- Overdose becomes a social issue
- PROSPECTS AND OPPORTUNITIES
- Continued stability ahead
- From seasonal hay fever prevention to year-round allergy prevention
- Self-medication as a growth driver
- CATEGORY DATA
- Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2019-2024
- Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2019-2024
- Table 20 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2020-2024
- Table 21 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2021-2024
- Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2024-2029
- Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2024-2029
- DIGESTIVE REMEDIES IN JAPAN
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Digestive remedies maintains its growth trend, continuing its rebound from the pandemic
- Price revision for the leading player in diarrhoeal remedies
- Motion sickness remedies sees family-oriented promotions
- PROSPECTS AND OPPORTUNITIES
- Various factors expected to drive a slowdown in growth
- Increase in retailers’ private label lines and channels set to intensify the competition
- Potential for new cases of motion sickness from emerging technologies
- CATEGORY DATA
- Table 24 Sales of Digestive Remedies by Category: Value 2019-2024
- Table 25 Sales of Digestive Remedies by Category: % Value Growth 2019-2024
- Table 26 NBO Company Shares of Digestive Remedies: % Value 2020-2024
- Table 27 LBN Brand Shares of Digestive Remedies: % Value 2021-2024
- Table 28 Forecast Sales of Digestive Remedies by Category: Value 2024-2029
- Table 29 Forecast Sales of Digestive Remedies by Category: % Value Growth 2024-2029
- DERMATOLOGICALS IN JAPAN
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Sales see negligible growth overall, with variations across categories
- “Strong” steroids enter the OTC space
- Expansion of the femcare concept
- PROSPECTS AND OPPORTUNITIES
- Upcoming positive and negative factors for dermatologicals
- Active development of dermatologicals by private label
- Marketing strategies for products which are embarrassing to buy in-store
- CATEGORY DATA
- Table 30 Sales of Dermatologicals by Category: Value 2019-2024
- Table 31 Sales of Dermatologicals by Category: % Value Growth 2019-2024
- Table 32 NBO Company Shares of Dermatologicals: % Value 2020-2024
- Table 33 LBN Brand Shares of Dermatologicals: % Value 2021-2024
- Table 34 LBN Brand Shares of Hair Loss Treatments: % Value 2021-2024
- Table 35 Forecast Sales of Dermatologicals by Category: Value 2024-2029
- Table 36 Forecast Sales of Dermatologicals by Category: % Value Growth 2024-2029
- NRT SMOKING CESSATION AIDS IN JAPAN
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Slow and steady decline is maintained in 2024
- Switch to heated tobacco impacts NRT smoking cessation aids
- Corporate incentives to quit smoking
- PROSPECTS AND OPPORTUNITIES
- Prospect of tobacco tax increase could provide a short-term boost
- Municipal actions to limit smoking may impact sales
- Diversification from cigarettes creates a mixed picture
- CATEGORY INDICATORS
- Table 37 Number of Smokers by Gender 2019-2024
- CATEGORY DATA
- Table 38 Sales of NRT Smoking Cessation Aids by Category: Value 2019-2024
- Table 39 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2019-2024
- Table 40 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2020-2024
- Table 41 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2021-2024
- Table 42 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2024-2029
- Table 43 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2024-2029
- SLEEP AIDS IN JAPAN
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Many sleep-deprived consumers in Japan are not turning to sleep aids
- The potential for enlightenment about the importance of sleep
- Safety over efficacy can help reassure consumers
- PROSPECTS AND OPPORTUNITIES
- Value stagnation expected in the forecast period
- Promoting sleep as a positive lifestyle change in brand campaigns
- From competitors to collaborators
- CATEGORY DATA
- Table 44 Sales of Sleep Aids: Value 2019-2024
- Table 45 Sales of Sleep Aids: % Value Growth 2019-2024
- Table 46 NBO Company Shares of Sleep Aids: % Value 2020-2024
- Table 47 LBN Brand Shares of Sleep Aids: % Value 2021-2024
- Table 48 Forecast Sales of Sleep Aids: Value 2024-2029
- Table 49 Forecast Sales of Sleep Aids: % Value Growth 2024-2029
- EYE CARE IN JAPAN
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Eye care struggles to achieve growth in 2024 due to low pollen symptoms
- Targeting all generations, one by one
- Growth of all-in-one products
- PROSPECTS AND OPPORTUNITIES
- Increase in eye problems, and alternative solutions
- Change of class will lead to distribution changes
- A move towards new forms of differentiation
- CATEGORY DATA
- Table 50 Sales of Eye Care by Category: Value 2019-2024
- Table 51 Sales of Eye Care by Category: % Value Growth 2019-2024
- Table 52 NBO Company Shares of Eye Care: % Value 2020-2024
- Table 53 LBN Brand Shares of Eye Care: % Value 2021-2024
- Table 54 Forecast Sales of Eye Care by Category: Value 2024-2029
- Table 55 Forecast Sales of Eye Care by Category: % Value Growth 2024-2029
- WOUND CARE IN JAPAN
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Stability in wound care in value terms
- Momentum for hydrocolloid wound care products
- Strong impact of a simple but new idea
- PROSPECTS AND OPPORTUNITIES
- Wound care expected to face diverse demands
- Family-oriented and disaster prevention awareness-raising activities
- Differentiation through anime collaborations and unique designs
- CATEGORY DATA
- Table 56 Sales of Wound Care by Category: Value 2019-2024
- Table 57 Sales of Wound Care by Category: % Value Growth 2019-2024
- Table 58 NBO Company Shares of Wound Care: % Value 2020-2024
- Table 59 LBN Brand Shares of Wound Care: % Value 2021-2024
- Table 60 Forecast Sales of Wound Care by Category: Value 2024-2029
- Table 61 Forecast Sales of Wound Care by Category: % Value Growth 2024-2029
- VITAMINS IN JAPAN
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Liposomal vitamin C gains popularity
- Tonics recovers, but struggles to compete with energy drinks
- Seasonality of vitamin C, which is more popular in the summer
- PROSPECTS AND OPPORTUNITIES
- Vitamins expected to maintain a strong performance
- How changes in vitamin standards and research findings could affect future demand
- Competition with other categories
- CATEGORY DATA
- Table 62 Sales of Vitamins by Category: Value 2019-2024
- Table 63 Sales of Vitamins by Category: % Value Growth 2019-2024
- Table 64 Sales of Multivitamins by Positioning: % Value 2019-2024
- Table 65 NBO Company Shares of Vitamins: % Value 2020-2024
- Table 66 LBN Brand Shares of Vitamins: % Value 2021-2024
- Table 67 Forecast Sales of Vitamins by Category: Value 2024-2029
- Table 68 Forecast Sales of Vitamins by Category: % Value Growth 2024-2029
- DIETARY SUPPLEMENTS IN JAPAN
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Dietary supplements sees positive and negative movements
- Impact of “benikoji issue”
- Kirin acquires Fancl to expand its areas of business
- PROSPECTS AND OPPORTUNITIES
- Using dietary supplements to prevent illness and maintain health will attract attention
- The rise of femtech
- The expansion of private label
- CATEGORY DATA
- Table 69 Sales of Dietary Supplements by Category: Value 2019-2024
- Table 70 Sales of Dietary Supplements by Category: % Value Growth 2019-2024
- Table 71 Sales of Dietary Supplements by Positioning: % Value 2019-2024
- Table 72 NBO Company Shares of Dietary Supplements: % Value 2020-2024
- Table 73 LBN Brand Shares of Dietary Supplements: % Value 2021-2024
- Table 74 Forecast Sales of Dietary Supplements by Category: Value 2024-2029
- Table 75 Forecast Sales of Dietary Supplements by Category: % Value Growth 2024-2029
- WEIGHT MANAGEMENT AND WELLBEING IN JAPAN
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Sales decline due to the impact of the red yeast rice issue
- Shift from dieting to emphasising overall health and nutrition
- The trend of promoting nutritional balance over dieting
- PROSPECTS AND OPPORTUNITIES
- A return to growth in the forecast period, with a focus on preventive care
- Diversification of “health”
- Targeting different consumer groups in supplement nutrition drinks
- CATEGORY DATA
- Table 76 Sales of Weight Management and Wellbeing by Category: Value 2019-2024
- Table 77 Sales of Weight Management and Wellbeing by Category: % Value Growth 2019-2024
- Table 78 NBO Company Shares of Weight Management and Wellbeing: % Value 2020-2024
- Table 79 LBN Brand Shares of Weight Management and Wellbeing: % Value 2021-2024
- Table 80 Forecast Sales of Weight Management and Wellbeing by Category: Value 2024-2029
- Table 81 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2024-2029
- SPORTS NUTRITION IN JAPAN
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- The growth of sports protein products continues
- Sports protein products takes in health trends
- Promotion using athletes and personalities
- PROSPECTS AND OPPORTUNITIES
- Fusion of sports nutrition and complete nutrition concepts
- Approaching the older consumer group
- Protein likely to increasingly be chosen over alcohol
- CATEGORY DATA
- Table 82 Sales of Sports Nutrition by Category: Value 2019-2024
- Table 83 Sales of Sports Nutrition by Category: % Value Growth 2019-2024
- Table 84 NBO Company Shares of Sports Nutrition: % Value 2020-2024
- Table 85 LBN Brand Shares of Sports Nutrition: % Value 2021-2024
- Table 86 Forecast Sales of Sports Nutrition by Category: Value 2024-2029
- Table 87 Forecast Sales of Sports Nutrition by Category: % Value Growth 2024-2029
- HERBAL/TRADITIONAL PRODUCTS IN JAPAN
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- The end of the pandemic impacts sales of herbal/traditional products
- Utilising Kampo to reach a new customer base
- Business opportunities in PFC balance
- PROSPECTS AND OPPORTUNITIES
- Capturing the wellness trend
- Strengthening communication to attract consumers
- A more holistic approach could attract a wider audience
- CATEGORY DATA
- Table 88 Sales of Herbal/Traditional Products by Category: Value 2019-2024
- Table 89 Sales of Herbal/Traditional Products by Category: % Value Growth 2019-2024
- Table 90 NBO Company Shares of Herbal/Traditional Products: % Value 2020-2024
- Table 91 LBN Brand Shares of Herbal/Traditional Products: % Value 2021-2024
- Table 92 Forecast Sales of Herbal/Traditional Products by Category: Value 2024-2029
- Table 93 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2024-2029
- PAEDIATRIC CONSUMER HEALTH IN JAPAN
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Outbreaks of common colds, influenza, and COVID-19 support sales
- Protein for children increasingly valued
- Dietary supplements for families
- PROSPECTS AND OPPORTUNITIES
- The impact of the low birth rate in Japan
- Solutions to “modern malnutrition”
- The continued development of paediatric medicines due to government intervention
- CATEGORY DATA
- Table 94 Sales of Paediatric Consumer Health by Category: Value 2019-2024
- Table 95 Sales of Paediatric Consumer Health by Category: % Value Growth 2019-2024
- Table 96 NBO Company Shares of Paediatric Consumer Health: % Value 2020-2024
- Table 97 LBN Brand Shares of Paediatric Consumer Health: % Value 2021-2024
- Table 98 Forecast Sales of Paediatric Consumer Health by Category: Value 2024-2029
- Table 99 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2024-2029
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook